Abstract: . . .  processes and renewable bioresources to produce improved health and sustainable growth and development ”.   Building visions for the development of the bioeconomy Identifying technical, financial, human capital, regulatory bottlenecks Providing as much as possible a quantifiable benefit analysis of the main segments Providing a road map of necessary policy choices ahead   IBIOTECHNOLOGY DIVISION  . . .
. . .  T-Shirts!   BIOTECHNOLOGY DIVISION           Cargill-Dow (Nebraska)   BIOTECHNOLOGY DIVISION           Market Potential   Recognise opportunities to realise latent value natural processes. Significant economic potential in manufacturing and processing industry (sector provides 17% direct economic value in OECD countries - big pharma another 2-3%). But must avoid over-hype and exact estimates missing - need to be generated.   BIOTECHNOLOGY DIVISION           Measuring the Biobased Economy   Country strategies : visions, roadmaps, foresight. Goal setting Measuring activity : eg investment, jobs, numbers of firms, churning, patents. Definitions, methodology . . .
--1711,2,428,1484,8555